- Sanjeet Bagcchi
- 1Kolkata
The Indian government has issued an order with “immediate effect” to researchers, medical institutions, and drug companies about the criteria they must follow to win approval for clinical trials of new drugs.
The order from the drug controller general of India (DCGI), which was issued on 5 September,1 aimed to improve the regulation of clinical trials in the country. It stated that, for new trials to be approved, they must include information on an assessment of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.